Dr Guy Sauvageau

Institute for Research in Immunology and Cancer, Université de Montréal

Dr Guy Sauvageau
Progress in leukemias

Dr Guy Sauvageau at the Institute for Research in Immunology and Cancer, Université de Montréal, led a study of 2 forms of acute myeloid leukemia (AML) and identified for the first time a pattern of gene activity shared by these 2 subsets. This new information should advance how AML is diagnosed and how treatments can be tailored to improve survival.

Reference: Nature Genetics, September 2015


Photo credit: Institute for Research in Immunology and Cancer (IRIC) at the Université de Montréal (UdeM), www.iric.ca.